EVMN
Evommune Inc
NYSE · Biotechnology
$17.31
+0.65 (+3.90%)
Open$17.38
Previous Close$16.66
Day High$17.60
Day Low$17.00
52W High$24.03
52W Low$13.89
Volume—
Avg Volume339.7K
Market Cap545.68M
P/E Ratio—
EPS$-2.22
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+337.9% upside
Current
$17.31
$17.31
Target
$75.80
$75.80
$52.19
$75.80 avg
$91.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 7.34M | 78.02M | 75.69M |
| Net Income | -70,021,317 | -16,723,517 | -20,379,208 |
| Profit Margin | -954.4% | -21.4% | -26.9% |
| EBITDA | -72,070,384 | -28,105,243 | -27,281,553 |
| Free Cash Flow | — | -11,355,754 | -12,035,038 |
| Rev Growth | — | -7.7% | +21.3% |
| Debt/Equity | 0.21 | 0.34 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |